FDA
Treprostinil
The FDA lists this product in 22 strengths and forms.
Composition
- Active ingredients
- TREPROSTINIL 0.25MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TREPROSTINIL 5MG/ML · InjectableANDA210214-003 · Prescription
- TREPROSTINIL 1MG/ML · InjectableANDA210214-001 · Prescription
- TREPROSTINIL 10MG/ML · InjectableANDA210214-004 · Prescription
- TREPROSTINIL 2.5MG/ML · InjectableANDA210214-002 · Prescription
- TREPROSTINIL 5MG/ML · InjectableANDA206648-003 · Prescription
- TREPROSTINIL 1MG/ML · InjectableANDA206648-001 · Prescription
- TREPROSTINIL 10MG/ML · InjectableANDA206648-004 · Prescription
- TREPROSTINIL 2.5MG/ML · InjectableANDA206648-002 · Prescription
- TREPROSTINIL 10MG/ML · InjectableANDA209382-004 · Discontinued
- TREPROSTINIL 2.5MG/ML · InjectableANDA209382-002 · Discontinued
- TREPROSTINIL 5MG/ML · InjectableANDA209382-003 · Discontinued
- TREPROSTINIL 1MG/ML · InjectableANDA209382-001 · Discontinued
- TREPROSTINIL 10MG/ML · Injectable
At a glance
- Brand name
- Treprostinil
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Actavis Labs
- Status
- Tentative approval
- FDA approval
- 3 Apr 2023
- Application
- ANDA208906-002